# TAP and IMS for HIPEC

> **NCT04981639** · PHASE3 · COMPLETED · sponsor: **Gangnam Severance Hospital** · enrollment: 81 (actual)

## Conditions studied

- Cytoreductive Surgery

## Interventions

- **PROCEDURE:** IVPCA
- **PROCEDURE:** TAP
- **PROCEDURE:** IMS

## Key facts

- **NCT ID:** NCT04981639
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-21
- **Primary completion:** 2022-06-14
- **Final completion:** 2022-06-14
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04981639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04981639, "TAP and IMS for HIPEC". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT04981639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*